Pregnant or breast-feeding females
Pregnant or breast feeding females.
Pregnant or breast feeding females.
Pregnant or breast feeding females.
Females who are pregnant or breast feeding are excluded since there are unknown teratogenic effects of these agents
Pregnant or breast-feeding females
Pregnant or breast feeding females
Pregnant or breast-feeding females are excluded
Females who are pregnant or breast-feeding
Pregnant or breast-feeding females
Pregnant or breast feeding females
Pregnant or breast-feeding females
Pregnant or breast-feeding females
Females who are pregnant or breast-feeding
Pregnant or breast-feeding females.
Pregnant or breast-feeding females.
Pregnant or breast feeding females
Pregnant or breast-feeding females
Pregnant or breast feeding females are excluded
Pregnant and breast-feeding females
Pregnant or breast feeding females
Pregnant or breast-feeding females are excluded
Pregnant or breast feeding females
Pregnant or breast feeding females
Breast feeding females
Females who are pregnant or breast-feeding
Relapsed/refractory MCL: Pregnant or breast feeding females
Females who are pregnant or breast-feeding
Pregnant or breast-feeding females
Females who are pregnant or breast-feeding.
Pregnant or breast feeding females.
Pregnant or breast-feeding females
Pregnant or breast-feeding females
Females who are pregnant or breast-feeding
Pregnant or breast feeding females
Pregnant or breast-feeding females
Pregnant or breast-feeding females
Non pregnant, non-breast feeding females under active contraception
Pregnant or breast-feeding females or females who intend to become pregnant during study participation.
Pregnant or breast-feeding females
Pregnant or breast-feeding females
Pregnant or breast-feeding females
Females must not be pregnant or breast-feeding
Pregnant or breast-feeding females
Females who are pregnant or breast feeding are not eligible for this study
Females who are breast-feeding or pregnant
Pregnant or breast feeding females
Pregnant or breast-feeding females
Pregnant or breast feeding females
Pregnant or breast-feeding females; patients who become pregnant during active therapy will be immediately removed from the study
Females who are pregnant or breast-feeding
Pregnant or breast feeding females
Pregnant or breast feeding females
Pregnant or breast-feeding females
Breast feeding females
Females who are pregnant or breast feeding
Pregnant or breast-feeding; pregnancy testing will be performed on all menstruating females within  days prior to study enrollment
Pregnant or breast feeding females.
Pregnant or breast-feeding; pregnancy testing will be performed on all menstruating females within  days prior to study enrollment
Lactating or breast feeding females
Pregnant or breast-feeding females
Pregnant or breast feeding females are not eligible
Females who are pregnant or breast-feeding
Females who are pregnant or are breast-feeding.
For females, if they are pregnant or breast-feeding
Females who are breast-feeding or pregnant
Pregnant or breast feeding females
Breast feeding or pregnant females
Breast feeding or pregnant females
Breast feeding females
Pregnant or breast-feeding females
Pregnant or breast-feeding females.
Pregnant, lactating or actively breast feeding females.
Breast feeding females
Lactating females who are actively breast feeding.
Pregnant or breast-feeding females
Pregnant or breast-feeding females
Females who are pregnant or might be pregnant or are breast-feeding
Females who are pregnant or breast feeding
Females who are pregnant or breast feeding at the time of screening will not be eligible for this study
Pregnant or breast feeding females
Pregnant or breast feeding females
Pregnancy/breast feeding: females who are pregnant or breast feeding at the time of study entry are not eligible
Pregnant or breast-feeding females
